Neuroprotection with amifostine in the 1st-line treatment of advanced ovarian cancer with carboplatin/taxane-based chemotherapy - a double-blind, placebo-controlled, randomized phase II-study from the AGO Ovarian Cancer Study Group. - Hilpert,F.; Stähle,A.; Tomé,O. (Proc Am Soc Clin Oncol, 2003)